Fellow wins 2017 Roger de Spoelberch Prize

The Academy is delighted that Professor David Rubinsztein FRS FMedSci has been awarded the 2017 Roger de Spoelberch Prize for research into neurodegeneration.

The award, worth  €750,000, celebrates excellence in neurodegenerative disease research.

Professor Rubinsztein, who is the ninth recipient of the annual award, was celebrated by the judging committee for the insights his work has provided into autophagy and its potential for impacting on neurodegenerative disorders. Autophagy is the process by which cells break down components that are no longer needed, so as to recycle their constituent parts. 

Professor Rubinsztein is Professor of Molecular Neurogenetics at the University of Cambridge and Deputy Director of the Cambridge Institute for Medical Research.

Speaking to the University of Cambridge, Professor Rubinszstein said: “I am extremely grateful to the Roger de Spoelberch Foundation for this great honour. This award will provide tremendous encouragement and significant support for me and my lab’s future efforts. Of course, this prize is a sign of recognition for my coworkers in the lab over the years. I have been truly fortunate to have worked with wonderful people, who are excellent scientists and collaborators. I am very grateful to them for making the lab a place I look forward to coming to each day.”

The Roger de Spoelberch Foundation, based in Geneva, supports and funds research into neurodegenerative diseases and psychiatric disorders. 

Staff contacts

Clinical Academia for the Future: Research Leaders and Innovators

Book Now

Remaining Resilient in Research

Book Now

The UK clinical research skills base

Book Now
View more
FB Twitter Instagram Youtube